Patent holdings for IPC class C07D 333/72

Total number of patents in this class: 85

10-year publication summary

5
5
5
9
5
4
4
8
5
0
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Zhejiang Jingxin Pharmaceutical Co., Ltd.
22
6
BASF SE
20580
4
Merck Patent GmbH
5877
4
Shanghai Jingxin Biomedical Co., Ltd.
16
4
Ambrx, Inc.
193
3
Shangyu Jingxin Pharmaceutical Co., Ltd.
9
3
Syngenta Participations AG
2715
2
Duke University
3035
2
Actelion Pharmaceuticals Ltd
552
2
Chugai Seiyaku Kabushiki Kaisha
1322
2
Kyushu University, National University Corporation
1636
2
Nippon Kayaku Kabushiki Kaisha
1432
2
Ryvu Therapeutics SA
40
2
Shanghai Jingxin Biology & Pharmaceutical Co., Ltd.
7
2
Glaxo Group Limited
4218
1
Novartis AG
11202
1
Samsung Electronics Co., Ltd.
140839
1
LG Chem, Ltd.
17685
1
The Regents of the University of California
19654
1
Janssen Pharmaceutica N.V.
3582
1
Other owners 39